O
OPK
Opko Health
1.350
-0.040-2.88%After Hours: 1.340 -0.010 -0.74%19:48 07/10 EDT
OPEN/PREV CLOSE1.390/1.390
TODAY RANGE1.350-1.405
VOL2.06M
MARKET CAP1.02B
52 WEEK RANGE0.9769-1.605
AVG VOL (3M)2.71M
% TURNOVER0.27%
TURNOVER--
P/E (TTM)-4.9306
% RANGE3.96%
EPS(TTM)-0.2738
P/E(FORWARD)-4.5763
P/B0.8462
BVPS1.595
DIVIDEND--
P/S1.689
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP510.21M
SHARES OUTSTANDING755.09M
NEXT EARNINGS07/29-08/03
FREE FLOAT377.93M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·07/02 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
Simply Wall St·07/02 19:33
OPKO Health (OPK) Ownership Update Draws Attention, Is The 55% Undervalued View Convincing?
Simply Wall St·06/24 00:36
OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus
TipRanks·06/18 20:57
Opko Health Shareholders Back Board, Equity and Auditors
Simply Wall St·06/16 18:33
OPKO Health (OPK) Stock Could Be 58.8% Undervalued After OPK8801001 Preclinical Update
TipRanks·06/16 13:36
Entera Bio and Opko Health present preclinical data for oral peptides
TipRanks·06/15 11:03
Piper Sandler Sticks to Their Buy Rating for Opko Health (OPK)
Simply Wall St·06/11 15:18
Should OPKO’s New 15% Nicoya Stake and RAYALDEE Terms Require Action From OPKO Health (OPK) Investors?
Simply Wall St·06/08 16:21
A Look At OPKO Health’s Valuation As Nicoya Agreement Expands RAYALDEE Opportunity In Asian Renal Care
Simply Wall St·06/06 02:27
OPKO Deepens Nicoya Alliance As RAYALDEE China Prospects Draw Focus
TipRanks·06/04 15:16
Private Markets: Anthropic files confidentially for IPO with SEC
TipRanks·05/26 17:47
H.C. Wainwright Sticks to Their Buy Rating for Opko Health (OPK)